Skip to main content
SpringerLink
Log in

Neurocognitive deficits attributed to androgen deprivation therapy in patients with prostate cancer should be reconsidered

  • Urology - Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ihrig A, Pernt PM, Zschäbitz S, Huber J, Friederich HC, Bugaj TJ et al (2023) Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer. Int Urol Nephrol. https://doi.org/10.1007/s11255-023-03712-z

    Article  PubMed  PubMed Central  Google Scholar 

  2. Jung G, Kim JK, Kim H, Lee J, Hong SK (2022) The association between prostatitis and risk of prostate cancer: a National Health Insurance Database study. World J Urol 40(11):2781–2787

    Article  CAS  PubMed  Google Scholar 

  3. Du H, Chen X, Zhang L, Liu Y, Zhan C, Chen J et al (2020) Experimental autoimmune prostatitis induces learning-memory impairment and structural neuroplastic changes in mice. Cell Mol Neurobiol 40(1):99–111

    Article  PubMed  Google Scholar 

  4. Huang Z, Jordan JD, Zhang Q (2023) Early life adversity as a risk factor for cognitive impairment and Alzheimer’s disease. Transl Neurodegener 12(1):25

    Article  PubMed  PubMed Central  Google Scholar 

  5. Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG (2019) Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci 26(1):33

    Article  PubMed  PubMed Central  Google Scholar 

  6. Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D et al (2018) Practice guideline update summary: Mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology 90(3):126–135

    Article  PubMed  PubMed Central  Google Scholar 

  7. Friberg AS, Brasso K, Larsen SB, Andersen EW, Krøyer A, Helgstrand JT et al (2021) Risk of depression after diagnostic prostate cancer workup—a nationwide, registry-based study. Psychooncology 30(11):1939–1947

    Article  PubMed  Google Scholar 

  8. Crump C, Stattin P, Brooks JD, Sundquist J, Bill-Axelson A, Edwards AC et al (2023) Long-term risks of depression and suicide among men with prostate cancer: a national cohort study. Eur Urol. https://doi.org/10.1016/j.eururo.2023.04.026

    Article  PubMed  Google Scholar 

  9. Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T et al (2017) Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiat 74(1):58–67

    Article  Google Scholar 

  10. Wang SM, Kang DW, Um YH, Kim S, Lee CU, Lim HK (2023) Depression is associated with the aberration of resting state default mode network functional connectivity in patients with amyloid-positive mild cognitive impairment. Brain Sci. https://doi.org/10.3390/brainsci13071111

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Author notes

  1. Xin Guan, Yongfeng Lao, Yanan Bai and Jian Wang have contributed equally to this work and share the first authorship.

Authors and Affiliations

  1. Second Clinical Medical College, Lanzhou University, Lanzhou, China

    Xin Guan, Yongfeng Lao, Yanan Bai, Jian Wang & Zhilong Dong

  2. Department of Urology, Lanzhou University Second Hospital, No. 82, Cuiyingmen, Chengguan District, Lanzhou, China

    Xin Guan, Yongfeng Lao, Jian Wang & Zhilong Dong

Authors
  1. Xin Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yongfeng Lao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yanan Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhilong Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhilong Dong.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guan, X., Lao, Y., Bai, Y. et al. Neurocognitive deficits attributed to androgen deprivation therapy in patients with prostate cancer should be reconsidered. Int Urol Nephrol 56, 143–144 (2024). https://doi.org/10.1007/s11255-023-03782-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-023-03782-z

Search

Navigation